Showing results (901-910 of 928) with videos related to
Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|June 16, 2025
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practiceMaria Luisa Brandi, Carolina R C Pieterman, Katherine A English, et al.The Lancet. Diabetes & Endocrinology|May 29, 2025
Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trialSofia Amylidi-Mohr, Giulia Zennaro, Sophie Schneider, et al.The Lancet. Diabetes & Endocrinology|February 29, 2024
5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension studyMichael Ej Lean, Wilma S Leslie, Alison C Barnes, et al.The Lancet. Diabetes & Endocrinology|March 21, 2024
Tight versus liberal blood-glucose control in the intensive care unit: special considerations for patients with diabetesChristian von Loeffelholz, Andreas L BirkenfeldThe Lancet. Diabetes & Endocrinology|April 1, 2024
Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a Swedish register-based cohort studyYuxia Wei, Shengxin Liu, Tomas Andersson, et al.The Lancet. Diabetes & Endocrinology|April 8, 2024
Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort studyVictoria Miller, David A Jenkins, Mahshid Dehghan, et al.The Lancet. Diabetes & Endocrinology|July 25, 2024
Artificial intelligence for diabetes care: current and future prospectsBin Sheng, Krithi Pushpanathan, Zhouyu Guan, et al.The Lancet. Diabetes & Endocrinology|February 4, 2024
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trialMichael J Koren, Olivier Descamps, Yoshiki Hata, et al.The Lancet. Diabetes & Endocrinology|September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trialsClaire Vale, Peter J Godolphin, David Fisher, et al.The Lancet. Diabetes & Endocrinology|October 7, 2024
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional studyPageof 93